A pair of new real-world COVID-19 vaccine studies show good protection against the Delta (B1617.2) variant, one from Scotland finding higher than 90% effectiveness in preventing death in adults and the other showing 93% efficacy against symptomatic infection in Israeli adolescents after the second dose. Both studies were published […]

Click here to view original web page at www.cidrap.umn.edu